Viewing Study NCT05555251


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2025-12-25 @ 9:45 PM
Study NCT ID: NCT05555251
Status: TERMINATED
Last Update Posted: 2024-12-16
First Post: 2022-09-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: BI-1607 in Combination with Trastuzumab in Subjects with HER2-positive Advanced Solid Tumors
Sponsor: BioInvent International AB
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module